New agents in the Treatment for Malignancies of the Salivary and Thyroid Glands

Por Mehra, Ranee, Cohen, Roger B.
Publicado em 2008

Antiangiogenic therapy for advanced renal cell carcinoma: Management of treatment-related toxicities

Por Cohen, Roger B., Oudard, Stéphane
Publicado em 2012

The Role of Cetuximab for the Treatment of Squamous Cell Carcinoma of the Head and Neck

Por Mehra, Ranee, Cohen, Roger B., Burtness, Barbara A.
Publicado em 2008

The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer

Por Tejani, Mohamedtaki A, Cohen, Roger B, Mehra, Ranee
Publicado em 2010

Immunotherapy for head and neck cancer: latest developments and clinical potential

Por Bauml, Joshua M., Cohen, Roger B., Aggarwal, Charu
Publicado no Ther Adv Med Oncol (2016)

Evaluating the safety and efficacy of axitinib in the treatment of advanced renal cell carcinoma

Por Gunnarsson, Orvar, Pfanzelter, Nicklas R, Cohen, Roger B, Keefe, Stephen M
Publicado no Cancer Manag Res (2015)

A Phase II study of Viagenpumatucel-l (HS-110) in combination with low-dose Cyclophosphamide versus physician's choice in patients with advanced non-small cell lung cancer

Por Cohen, Roger B, Nemunaitis, John, Gabrail, Nashat, Bazhenova, Lyudmila, Schreiber, Taylor H, Price, Melissa
Publicado no J Immunother Cancer (2014)

Phase I Dose Escalation, Pharmacokinetic and Pharmacodynamic Study of Naptumomab Estafenatox Alone in Patients With Advanced Cancer and With Docetaxel in Patients With Advanced Non...

Por Borghaei, Hossein, Alpaugh, Katherine, Hedlund, Gunnar, Forsberg, Göran, Langer, Corey, Rogatko, Andre, Hawkins, Robert, Dueland, Svein, Lassen, Ulrik, Cohen, Roger B.
Publicado em 2009

Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignancies

Por von Mehren, Margaret, Bookman, Michael, Meropol, Neal J., Weiner, Louis M., Sherman, Eric, Li, Jinhui, Knoblauch, Roland, Parekh, Trilok, Cohen, Roger B.
Publicado no Cancer Chemother Pharmacol (2015)

Phase I Study of the Safety, Tolerability, and Pharmacokinetics of Oral CP-868,596, a Highly Specific Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor in Patients...

Por Lewis, Nancy L., Lewis, Lionel D., Eder, Joseph P., Reddy, Nandi J., Guo, Feng, Pierce, Kristen J., Olszanski, Anthony J., Cohen, Roger B.
Publicado em 2009

Impact of neck dissection on long-term feeding tube dependence in head and neck cancer patients treated with primary radiation or chemoradiation

Por Lango, Miriam N., Egleston, Brian, Ende, Kevin, Feigenberg, Steven, D'Ambrosio, David J., Cohen, Roger B., Ahmad, Sidrah, Nicolaou, Nicos, Ridge, John A.
Publicado em 2010

Research Participants' High Expectations of Benefit in Early-Phase Oncology Trials: Are We Asking the Right Question?

Por Weinfurt, Kevin P., Seils, Damon M., Lin, Li, Sulmasy, Daniel P., Astrow, Alan B., Hurwitz, Herbert I., Cohen, Roger B., Meropol, Neal J.
Publicado em 2012

Survival outcome according to KRAS mutation status in newly diagnosed patients with stage IV non-small cell lung cancer treated with platinum doublet chemotherapy

Por Brady, Anna K., McNeill, Jonathan D., Judy, Brendan, Bauml, Joshua, Evans, Tracey L., Cohen, Roger B., Langer, Corey, Vachani, Anil, Aggarwal, Charu
Publicado no Oncotarget (2015)

Effects of Food on the Relative Bioavailability of Lapatinib in Cancer Patients

Por Koch, Kevin M., Reddy, Nandi J., Cohen, Roger B., Lewis, Nancy L., Whitehead, Bonnie, Mackay, Kathleen, Stead, Andrew, Beelen, Andrew P., Lewis, Lionel D.
Publicado no J Clin Oncol (2009)

A phase I dose-escalation study of selumetinib in combination with docetaxel or dacarbazine in patients with advanced solid tumors

Por LoRusso, Patricia M., Infante, Jeffrey R., Kim, Kevin B., Burris, Howard A., Curt, Gregory, Emeribe, Ugochi, Clemett, Delyth, Tomkinson, Helen K., Cohen, Roger B.
Publicado no BMC Cancer (2017)

Sunitinib in combination with paclitaxel plus carboplatin in patients with advanced solid tumors: phase I study results

Por Heath, Elisabeth I., Blumenschein, George R., Cohen, Roger B., LoRusso, Patricia M., LoConte, Noelle K., Kim, Sindy T., Ruiz-Garcia, Ana, Chao, Richard C., Wilding, George
Publicado em 2010

A Phase I, open-label, dose escalation study of afatinib, in a 3-week-on/1-week-off schedule in patients with advanced solid tumors

Por Marshall, John, Hwang, Jimmy, Eskens, Ferry A. L. M., Burger, Herman, Malik, Shakun, Uttenreuther-Fischer, Martina, Stopfer, Peter, Ould-Kaci, Mahmoud, Cohen, Roger B., Lewis, Nancy L
Publicado em 2012

A phase 1, open-label, dose-escalation study of BIIB022 (anti-IGF-1R monoclonal antibody) in subjects with relapsed or refractory solid tumors

Por von Mehren, Margaret, Britten, Carolyn D., Pieslor, Peter, Saville, Wayne, Vassos, Artemios, Harris, Sarah, Galluppi, Gerald R., Darif, Mohamed, Wainberg, Zev A., Cohen, Roger B., Leong, Stephen
Publicado em 2014

Phase I dose-escalation study of cabazitaxel administered in combination with gemcitabine in patients with metastatic or unresectable advanced solid malignancies

Por Rixe, Olivier, Puzanov, Igor, LoRusso, Patricia M., Cohen, Roger B., Morris, John C., Olowokure, Olugbenga O., Yin, Jian Y., Doroumian, Séverine, Shen, Liji, Olszanski, Anthony J.
Publicado no Anticancer Drugs (2015)

Nodal metastasis and elective nodal level treatment in sinonasal small-cell and sinonasal undifferentiated carcinoma: a surveillance, epidemiology and end results analysis

Por Ahn, Peter H, Mitra, Nandita, Alonso-Basanta, Michelle, Adappa, Nithin D, Palmer, James N, O'Malley, Bert W, Rassekh, Christopher H, Chalian, Ara, Cohen, Roger B, Lin, Alexander
Publicado no Br J Radiol (2016)